Archive for March 9th, 2010

• Mar 09, 2010

  No Comments

  Mitochondrial Dynamics in Alzheimers Disease: Opportunities for Future Treatment Strategies

  (Source:...
  
  

• Mar 09, 2010

  No Comments

  Soluble βamyloid1-42: a critical player in producing behavioural and biochemical changes evoking depressive-related state?

  Conclusions and implications: Our data suggest that soluble A[beta]-treated rats have a depressive, but not anxiogenic-like, profile, accompanied by brain region-dependent alterations in the expression of neurotrophins and 5-hydroxytryptaminergic neurotransmission. Hence, these alterations induced by soluble A[beta] might be sensitive indicators of early phases of AD and possible risk factors for the expression of neuropsychiatric...
  
  

• Mar 09, 2010

  No Comments

  [Visualization of amyloid with positron emission tomography : Useful improvement in the diagnosis of dementia?]

  Authors: Grimmer T, Drzezga A, Kurz A Imaging techniques for in vivo visualization of cerebral amyloid using positron emission tomography (PET) have been tested in clinical trails over the past 5 years. Based on a selected overview of the literature including our own studies the various radiopharmaceuticals are presented and the current...
  
  

• Mar 09, 2010

  No Comments

  Effect of Alzheimer’s disease genetic risk disclosure on dietary supplement use.

  CONCLUSIONS: In this sample of first-degree relatives receiving genetic susceptibility testing for AD, an APOE epsilon4+ genotype status was positively associated with dietary supplement use after risk disclosure. Such changes occurred despite the absence of evidence that supplement use reduces the risk of AD. Given the expansion of DTC genetic tests, this study highlights the...
  
  

• Mar 09, 2010

  No Comments

  Has medical science changed your life? Share your personal story and it could be published in The Sun newspaper

  Has medical science changed your life? Science: [So What? So everything] is a campaign that looks at what science is doing for us and how it will improve our future. (Source: Alzheimers...
  
  

• Mar 09, 2010

  No Comments

  Minorities’ higher Alzheimer’s risk

  Francisca Terrazas and other Latinas are about 1.5 times more likely than Anglos to develop Alzheimer's and other forms of dementia, a new report says. Read how her family copes. (Source: CNN.com -...
  
  

• Mar 09, 2010

  No Comments

  Alzheimer’s ‘Epidemic’ Hitting Minorities Hardest

  Blacks, Hispanics at much higher risk for the illness, which carries huge price tag, report finds Source: HealthDay Related MedlinePlus Pages: Alzheimer's Disease, Health Disparities (Source: MedlinePlus Health News)

  MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and...

  
  

• Mar 09, 2010

  No Comments

  Alzheimer’s Disease More Prevalent in Blacks, Hispanics

  WASHINGTON (MedPage Today) -- African Americans and Hispanics are much more likely than whites to develop Alzheimer’s disease and other dementias, according to new figures from the Alzheimer’s Association. (Source: MedPage Today...
  
  

• Mar 09, 2010

  No Comments

  Minorities more likely to suffer from Alzheimer’s: report

  Minorities are at significantly higher risk for developing Alzheimer's disease, finds a new report from the Alzheimer's Association in the U.S. that has implications for minorities in Canada as well. (Source: CTV...
  
  

• Mar 09, 2010

  No Comments

  State Roundup: N.Y. Drug Pricing, Vermont Hospital Ads, Massachusetts Nursing Homes And Anti-Psychotics

  Poughkeepsie Journal: A new report on New York drug prices, "issued by the New York Public Interest Research Group, Consumers Union, the Center for Medical Consumers and AARP, looked at the price of the 10 most popular drugs found in the state's pharmacies provided through a Freedom of Information Law...